Cyclerion Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
09 Aug 23 | SellUS$27 | Polaris Venture Partners, Inc. | Company | 8 | US$3.40 | |
19 May 23 | BuyUS$1,953,000 | Peter Hecht | Individual | 225,000 | US$8.68 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
VC/PE Firms | 138,955 | 5.47% |
Institutions | 408,046 | 16.1% |
Individual Insiders | 577,954 | 22.8% |
Hedge Funds | 691,769 | 27.2% |
General Public | 722,435 | 28.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
377,457 | US$1.2m | 4.14% | no data | |||
357,880 | US$1.1m | 0% | 0.02% | |||
169,460 | US$538.9k | 0% | 0.02% | |||
164,429 | US$522.9k | 11.3% | 100.0% | |||
162,819 | US$517.8k | -1.03% | no data | |||
138,955 | US$441.9k | 0% | 0.01% | |||
133,027 | US$423.0k | 0% | 100.0% | |||
100,303 | US$319.0k | 99.4% | no data | |||
36,113 | US$114.8k | 0% | 0.07% | |||
31,259 | US$99.4k | 1.66% | no data | |||
30,000 | US$95.4k | 0% | no data | |||
23,490 | US$74.7k | -42% | no data | |||
21,650 | US$68.8k | 0% | no data | |||
20,000 | US$63.6k | 0% | no data | |||
20,000 | US$63.6k | 0% | no data | |||
17,169 | US$54.6k | -4.62% | no data | |||
5,897 | US$18.8k | 557% | no data | |||
2,228 | US$7.1k | 707% | no data | |||
1,681 | US$5.3k | 0% | no data | |||
827 | US$2.6k | 0% | no data | |||
698 | US$2.2k | -15.2% | no data | |||
540 | US$1.7k | 0% | no data | |||
330 | US$1.0k | -63.8% | no data | |||
187 | US$594.3 | 0% | no data | |||
140 | US$444.9 | 0% | no data |